Invention Grant
- Patent Title: Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
-
Application No.: US14400052Application Date: 2013-05-09
-
Publication No.: US09657061B2Publication Date: 2017-05-23
- Inventor: Paul Laidler , Imre Farkas
- Applicant: Circassia Limited
- Applicant Address: GB Oxford
- Assignee: Circassia Limited
- Current Assignee: Circassia Limited
- Current Assignee Address: GB Oxford
- Agency: Clark & Elbing LLP
- Agent Susan M. Michaud
- Priority: GB1208293.9 20120511
- International Application: PCT/GB2013/051201 WO 20130509
- International Announcement: WO2013/167897 WO 20131114
- Main IPC: C07K7/08
- IPC: C07K7/08 ; A61K39/35 ; A61K45/06 ; A61K39/00
Abstract:
The present invention relates to a hydrochloride salt of a peptide consisting of the sequence of CPAVKRDVDLFLT (SEQ ID NO: 1) as well as its combinations with other peptides for immunosuppressive purposes.
Public/Granted literature
- US20150110820A1 HYDROCHLORIDE SALT OF PEPTIDE AND ITS USE IN COMBINATION WITH OTHER PEPTIDES FOR IMMUNOTHERAPY Public/Granted day:2015-04-23
Information query
